Ligand earnings beat by $1.16, revenue topped estimates
PositiveFinancial Markets

Ligand earnings beat by $1.16, revenue topped estimates
Ligand Pharmaceuticals has reported earnings that exceeded expectations by $1.16, with revenue also surpassing estimates. This strong financial performance highlights the company's robust growth and effective strategies, making it a significant player in the pharmaceutical industry. Investors and analysts are likely to view this as a positive indicator of Ligand's future potential.
— via World Pulse Now AI Editorial System






